Heroin and its metabolites: relevance to heroin use disorder
Open Access
- 8 April 2023
- journal article
- review article
- Published by Springer Nature in Translational Psychiatry
- Vol. 13 (1) , 1-16
Abstract
Heroin is an opioid agonist commonly abused for its rewarding effects. Since its synthesis at the end of the nineteenth century, its popularity as a recreational drug has ebbed and flowed. In the last three decades, heroin use has increased again, and yet the pharmacology of heroin is still poorly understood. After entering the body, heroin is rapidly deacetylated to 6-monoacetylmorphine (6-MAM), which is then deacetylated to morphine. Thus, drug addiction literature has long settled on the notion that heroin is little more than a pro-drug. In contrast to these former views, we will argue for a more complex interplay among heroin and its active metabolites: 6-MAM, morphine, and morphine-6-glucuronide (M6G). In particular, we propose that the complex temporal pattern of heroin effects results from the sequential, only partially overlapping, actions not only of 6-MAM, morphine, and M6G, but also of heroin per se, which, therefore, should not be seen as a mere brain-delivery system for its active metabolites. We will first review the literature concerning the pharmacokinetics and pharmacodynamics of heroin and its metabolites, then examine their neural and behavioral effects, and finally discuss the possible implications of these data for a better understanding of opioid reward and heroin addiction. By so doing we hope to highlight research topics to be investigated by future clinical and pre-clinical studies.Keywords
Funding Information
- Sapienza Università di Roma (RM11715C457665A1, RM11916B0E316F23, RG11816432C5E431)
This publication has 257 references indexed in Scilit:
- Maintenance Medication for Opiate Addiction: The Foundation of RecoveryJournal of Addictive Diseases, 2012
- The role of mu opioid receptors in psychomotor stimulation and conditioned place preference induced by morphine-6-glucuronideEuropean Journal of Pharmacology, 2012
- Hyperalgesia in Heroin Dependent Patients and the Effects of Opioid Substitution TherapyThe Journal of Pain, 2012
- Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neuronsBritish Journal of Pharmacology, 2012
- Negative Affect Heightens Opiate Withdrawal-Induced Hyperalgesia in Heroin Dependent IndividualsJournal of Addictive Diseases, 2011
- Heroin in brown, black and white: Structural factors and medical consequences in the US heroin marketInternational Journal of Drug Policy, 2009
- Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actionsProceedings of the National Academy of Sciences, 2009
- Oral heroin in opioid-dependent patients: Pharmacokinetic comparison of immediate and extended release tabletsEuropean Journal of Pharmaceutical Sciences, 2009
- Morphine Pharmacokinetics and Metabolism in HumansClinical Pharmacokinetics, 1993
- EFFECTS OF DIAMORPHINE, METHADONE, MORPHINE, AND PENTAZOCINE IN PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1969